Urinalysis Market Analysis and Forecast till 2031: By Product (Consumables {Dipsticks, Reagents, Disposables}, Instruments {Biochemical Urine Analyzer, Automated Urine Sediment Analyzer}), By Application (Urinary Tract Infections [UTI], Kidney Disease, Pr

Urinalysis Market Analysis and Forecast till 2031: By Product (Consumables {Dipsticks, Reagents, Disposables}, Instruments {Biochemical Urine Analyzer, Automated Urine Sediment Analyzer}), By Application (Urinary Tract Infections [UTI], Kidney Disease, Pregnancy, Diabetes), By End-Use (Clinical Laboratories, Hospitals, Home Healthcare), and Region

The global urinalysis market was valued at USD 3.4 billion in 2021 and it is anticipated to grow up to USD 6.2 billion by 2031, at a CAGR of 6.2% during the forecast period.

Urinalysis is also known as urine test that uses a urine sample to examine visual, chemical and microscopic aspects of urine to assess patient health. Urinalysis tests are commonly used by healthcare providers to check or monitor specific health disorders, damage to the kidney as well as to diagnose urinary tract infections.

Market Trends and Drivers

The growing geriatric population in developed and developing countries is anticipated to boost the market demand. The increasing prevalence of diabetes, liver, and renal diseases with aging will significantly contribute to the demand for urine tests in diagnosis. Incidence of such chronic conditions among elderly population lead to higher frequency of prescriptions for tests like creatinine, albumin, glucose, ketones, and bilirubin among others. According to the World Health Organization, the number of people aged 60 years and over is estimated to increase from 1 billion in 2020 to 1.4 billion by 2030. With increasing base of this age group, the industry is estimated to foresee tremendous growth. Additionally, higher risk of chronic kidney conditions with structural and functional changes in organs with aging will favour the testing volume.

Market Restraints and Challenges

The availability of refurbished instruments acts as a challenge in the growth of this market as these instruments offer the same functionalities as new equipment at a lower cost. Several end users, mainly small and medium-sized laboratories, opt for cost-effective and refurbished systems. In particular, the markets in developing countries, which are price-sensitive, prefer instruments that are cheap and offer similar functionalities. In the absence of well-grounded regulatory frameworks, there may be an influx of low-quality and refurbished products into the economy. Considering these factors, the demand for refurbished analyzers can be expected to increase in the coming years, as these systems offer the same functionalities at a lower cost. This is expected to hamper the revenue of companies offering branded analyzers, and thus restraining the overall growth of the market.

Global Urinalysis Market Segmental Overview

The report analyses the Global urinalysis market based on product, application, end-use, and region.

Global Urinalysis Market by Product

Based on product, it is segmented into consumables and instruments. Consumables are further bifurcated into reagents, dipsticks, and disposables. Instruments is subclassified into biochemical urine analyzer and automated urine sediment analyzers. The urinalysis instruments is expected to foresee significant growth from 2022 to 2028 due to the increasing preference by healthcare professionals for automated urine analyzers. Product developments have improved the automation process in urinalysis allowing accurate test results in case of complicated and serious illness. Additionally, infrastructure development in facilities leading to increasing adoption such advanced instruments will strengthen the segment growth potential in the coming years.

Global Urinalysis Market by Application

Based on application, it is segmented into urinary tract infection, kidney diseases, pregnancy, diabetes, and others. The urinary tract infections (UTI) segment is likely to dominate the market during the forecast period due to increasing incidence rate of urinary tract infections in developed and developing nations. For instance, according to the National Kidney Foundation, the UTIs lead to approximately 10 million physician visits each year in the U.S. and are highly prevalent among women. Further, the prevalence of risk factors that possess high risk of UTI will contribute to the existing disease burden. Thus, growing availability and accessibility of diagnostic products across developed regions for early disease diagnosis will positively influence the segment demand.

Global Urinalysis Market by End-use

Based on end-use, it is segmented into hospitals, clinical laboratories, home healthcare and others. The clinical laboratories segment is likely to dominate the urinalysis market during the forecast period. As clinical laboratories offer various advantages that helps in determining a course of action or treatment for a patient, the facilities are anticipated to foresee increased volume of urinalysis that will contribute to the market expansion. Additionally, collaboration of clinical laboratories and hospital settings for various diagnostic tests to reduce cost, time and human resources is expected to impel the urinalysis market growth. Moreover, availability of skilled administrators and specialists in settings will drive the customer preference towards clinical laboratories.

Geographical Analysis of Global Urinalysis Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is accounted for the majority of market share during the forecast period. Increasing prevalence of chronic diseases coupled with growing awareness regarding the early disease diagnosis will boost the regional market share. For instance, according to the report published by the Centers for Disease Control and Prevention (CDC) in 2020, more than 15% of adults in the U.S. were estimated to have CKD. Additionally, as per the report of National Diabetes Statistics in 2020, 34.2 million i.e., 10.5% of the U.S. population had diabetes in the year. Thus, incidence of such conditions that require urine examination or urinalysis at frequent intervals will stimulate the market forecasts in the region. Moreover, extensive research and development activities performed by several research laboratories and presence of major market players in the region will stimulate the market share.

Major Players in the Global Urinalysis MarketCOVID-19 Impact

The urinalysis industry continued to witness significant revenue growth during the COVID-19 pandemic. The high risk of COVID-19 infection among patients with existing history of chronic kidney disease (CKD) led to increased demand for routine urinalysis during the period. Availability of home testing products allowed such patients to effectively manage disease diagnosis at home without visiting physician offices. Further, as per the data by the European Kidney Health Alliance, nearly 58% of hospitalized COVID-19 patients were affected by Acute Kidney Injury (AKI) with an associated mortality rate of more than 30%. Thus, the increased risk of CKD among COVID-19 patients has also stimulated the demand for urinalysis in healthcare settings and contributed to the urinalysis market share

Recent Developments

• In April 2022, Thermo Fisher Scientific launched newest Raman spectroscopic analyzer such as Ramina Process Analyzer, is designed to eliminate much of the complexity inherent to Raman spectroscopy measurements to prioritize user accessibility. This analyzer offers non-destructive, continuous analysis without the need for sample preparation.
• In February 2021, 77 Elektronika Kft. announced the launch of LabStrip U mALB/CREA urine test strips. The product is intended for the rapid and semi-quantitative recognition of creatinine and albumin compounds in native urine. Such developments are expected to strengthen the company’s product offerings in the emerging markets.
• In January 2021, ARKRAY, Inc. (Japan) launched AutionIDaten AE-4070 compact automated urine analyzer.
• In August 2020, Sysmex America, Inc. announced an exclusive agreement with Siemens Healthineers that granted North American rights to distribute and service Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use.

Frequently Asked Questions

Q1. How big is the urinalysis market?Ans. The global urinalysis market size was USD 3.4 Billion in 2021 and is anticipated to reach USD 6.2 Billion in 2031, growing at a rate of 6.2% from 2022 to 2031.Q2. What is urinalysis market growth rate?Ans. The growth rate of the urinalysis market is 6.2%.Q3. Which region holds a major market share for the urinalysis market?Ans. North America holds a major market share of the urinalysis market in 2021.Q4. Which segment accounted for the largest urinalysis market share?Ans. By end user, the hospitals segment accounted for the largest urinalysis market share.Q5. Who are the key players in the urinalysis market?Q6. What are the factors driving the urinalysis market growth?Ans. The major factors driving the growth of the market are the increased demand for routine urinalysis across the globe.Q7. What are the key growth strategies of urinalysis market players?Ans. The key growth strategies of urinalysis market players are product launch and product approval.Q8. Which region will provide more business opportunities for the urinalysis market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the urinalysis market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.